Author Question: The Roux-en-Y gastric bypass procedure produces weight loss by a. reducing plasma leptin levels. ... (Read 103 times)

robinn137

  • Hero Member
  • *****
  • Posts: 544
The Roux-en-Y gastric bypass procedure produces weight loss by
 
  a. reducing plasma leptin levels.
  b. decreasing plasma ghrelin levels.
  c. decreasing plasma PYY levels.
  d. increasing plasma PYY levels.
  e. increasing plasma CCK levels.

Question 2

Which of the following is true of leptin?
 
  a. Leptin is a product of protein metabolism.
  b. Leptin levels are decreased during overeating and obesity.
  c. Mutations of the leptin gene are the most common cause of obesity.
  d. Plasma leptin levels are related to body fat content only in obese persons.
  e. Obese humans have high plasma leptin levels and are insensitive to leptin injection.



Melissahxx

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

Answer: b. decreasing plasma ghrelin levels.

Answer to Question 2

Answer: e. Obese humans have high plasma leptin levels and are insensitive to leptin injection.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The National Institutes of Health have supported research into acupuncture. This has shown that acupuncture significantly reduced pain associated with osteoarthritis of the knee, when used as a complement to conventional therapies.

Did you know?

About one in five American adults and teenagers have had a genital herpes infection—and most of them don't know it. People with genital herpes have at least twice the risk of becoming infected with HIV if exposed to it than those people who do not have genital herpes.

Did you know?

More than 20 million Americans cite use of marijuana within the past 30 days, according to the National Survey on Drug Use and Health (NSDUH). More than 8 million admit to using it almost every day.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library